Printer Friendly
The Free Library
19,588,385 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

An in-Dept View of Sankyo Co Ltd Covering Their 28 Deals Made, and 34 Partnering Companies over a Five Year Period.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c26992 ) has announced the addition of Sankyo Sankyo means "third one" in Japanese. It may refer to:
  • Several companies, such as Sankyo Pharma and Sankyo Co., Ltd..
  • A principle in Aikido referred to as "third teaching" (which includes certain wristlocks).
 Co Ltd Deals Briefing to their offering.

Description

Sankyo Co Ltd Deals briefing provides an in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 view of the 28 deals made by Sankyo Co Ltd and its subsidiaries with 34 partnering companies between 2000 and 2005, in a clear and accessible PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format.  format.

Chapter 1: Company profile

An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January January: see month.  2000 and July July: see month.  2005.

Every deal is fully categorized cat·e·go·rize  
tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es
To put into a category or categories; classify.



cat
, includes a detailed description, and includes financials such as headline value, upfront payments and royalty Compensation for the use of property, usually copyrighted works, patented inventions, or natural resources, expressed as a percentage of receipts from using the property or as a payment for each unit produced.  rates, where disclosed dis·close  
tr.v. dis·closed, dis·clos·ing, dis·clos·es
1. To expose to view, as by removing a cover; uncover.

2. To make known (something heretofore kept secret).
.
Scope
The report contains:
a brief company profile including subsidiary names
financial information where disclosed
a deals overview
specialized indexes including deals by partner company, subsidiary
company, therapy focus and development stage
a detailed listing of the company's deals and alliances.

Key questions answered
Sankyo Co Ltd Deals briefing provides a comprehensive summary of the
deals and alliances announced by the company and its subsidiaries
between January 2000 and July 2005. This report helps in:
identifying active partners
tracking competitor activity
benchmarking deals
comparing the finances of different deal types.

Sankyo Co Ltd Deals briefing brings all relevant partnering deals
into one place, providing a reference to deal making by Sankyo Co
Ltd.

Forecasts, projections, market estimates
This report provides: a financial summary table detailing the yearly
total revenues, pharma revenues, R&D spend and profit of the
company; and a series of tables detailing the number of deals made
by deal type, by therapy focus, by development stage and by industry
sector.

Who should buy the report
This report is essential reading for board and executive management,
and individuals in:
business development
licensing/partnering
deal making
business strategy
marketing and promotion
distribution and manufacturing (including contract services).

Topics Covered
Introduction
About Partneringdesk Deals briefings
Chapter 1: Company profile
Chapter 2: Financial data and deals overview
Chapter 3: Summary of deals
Deals involving Sankyo Co Ltd by partner company
Deals involving Sankyo Co Ltd by subsidiary
Deals involving Sankyo Co Ltd by therapy focus
Deals involving Sankyo Co Ltd by development stage
Chapter 4: List of deals
Glossary
List of Tables
Table 2.1 Sankyo Co Ltd financial summary
Table 2.2 Sankyo Co Ltd deals by deal type
Table 2.3 Sankyo Co Ltd deals by therapy focus
Table 2.4 Sankyo Co Ltd deals by development stage
Table 2.5 Sankyo Co Ltd deals by industry sector

Companies Mentioned
Luitpold Pharmaceuticals
Sankyo Pharma


For more information visit http://www.researchandmarkets.com/reports/c26992
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Company Profile
Geographic Code:9JAPA
Date:Nov 16, 2005
Words:513
Previous Article:Putnam CEO Views Retirement Landscape, Calls for Changes from Fund Industry.
Next Article:UK Cable Operator NTL Strengthens its Position in the Triple-Play Sector by Acquiring and Merging with Its Competitor Telewest.
Topics:



Related Articles
Telik and Sankyo Announce Major Drug Screening Collaboration Focused on Biologically Active Compounds For Up to 10 Targets.
Shionogi & Co Ltd, a Company Report from 2000-2005 Covering Deals, Partnering Companies and Financial Information.
Sankyo to Manufacture, Distribute Olmetic Antihypertensive Drug in China.
2006 top 35 global reinsurance groups.
Daiichi Sankyo to Invest in the Healthcare Venture Fund.
Daiichi Pharmaceutical Korea to Become Wholly Owned Subsidiary of Daiichi Pharmaceutical.
Sanko Lifetech Transfers Animal Health Products Business to Novartis Animal Health.
Daiichi Sankyo Announces Completion of Phase I Trial on the Anti-influenza Drug CS-8958.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles